Former U.S. President Donald Trump has been criticized in Japan for his advocacy of a certain antipyretic, or fever-reducing drug. The news unfolds as Trump champions the use of the medicine, even as public opinion and official health advice in Japan caution against its overuse. Concerns are primarily based on potential side effects and misinformation about the drug's effectiveness.

Japan holds high respect for expert opinion and consensus in the field of medicine. Assertions from influential figures that contradict the authorities or promote potentially harmful health practices are often met with societal disapproval. In this case, Trump's endorsement of the antipyretic drug stirs controversy, especially due to the potential health risks the over-consumption of such drugs can pose to individuals.

In contrast, the U.S often entertains diverse opinions and debates about drugs and treatments, with public figures, including politicians, occasionally promoting specific medications. However, Trump's advocacy for unproven or controversial treatments has also sparked criticism stateside.